Founded in Quebec City in 2015, diaMentis develops a technology resulting from the research work of Laval University to develop a tool to aid in the diagnosis of mental health disorders.

Financial contributions have been granted to Laval University by the Consortium québécois sur la découverte du médicament (CQDM) and by the Canadian Institutes for Health Research (CIHR). Support from many important partners, such as the team from the Société de valorisation SOVAR, and many strategic investors, have also enabled this high-tech project to take shape.

diaMentis develops a non-invasive test based on reliable analysis of information from ERG assessment (biosignatures).

diaMentis wants to improve patient care by providing a tool to help clinicians make an objective and quantitative diagnosis that could be considered for inclusion in standardized medical treatment guidelines.

diaMentis develops a software as medical device (SaMD) that analyses information from a simple examination of the eye (electroretinography).

diaMentis is a spin-off from Laval University.  Its team includes experienced life science entrepreneurs who have contributed to the development of many world-renowned companies.

The team

Normand Tremblay

C.Dir., M.Sc., C.Adm., C.M.C.

Co-founder and CEO

Bernard Guimont

BA, C.Adm.

Vice president and CFO

Claude Hariton

PhD, DSc

Vice President and Chief Scientific Officer

Marc Guérin


Medical Executive Director

Justine Kelly Lalonde


Vice President, Clinical Affairs

Alexandre Sasseville


ERG Manager

Claudia Émond


Manager, Biostatistics and Data Management

Frédéric Thibault


Project Manager


To increase the efficiency of care for those affected with mental illnesses, with the integration of a tool to aid in the diagnosis, adapted to the needs and benefits of all users and stakeholders.


Develop a flagship company offering an objective aid in the diagnosis of severe mental disorders within the framework of multiple healthcare systems, on the world stage through strategic partnerships.

Value Proposition

Improve patient healthcare by integrating a new approach to offer healthcare professionals a non-invasive tool to aid in the diagnosis of mental health disorders, with sufficient performance in terms of classification, value, ease of use and accessibility.